Evidence-Based Medicine Guidelines
Intravesical gemcitabine for non-muscle invasive bladder cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Gemcitabine for Non-muscle Invasive Bladder Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457483/all/Intravesical_gemcitabine_for_non_muscle_invasive_bladder_cancer.
Intravesical gemcitabine for non-muscle invasive bladder cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457483/all/Intravesical_gemcitabine_for_non_muscle_invasive_bladder_cancer. Accessed October 6, 2024.
Intravesical gemcitabine for non-muscle invasive bladder cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457483/all/Intravesical_gemcitabine_for_non_muscle_invasive_bladder_cancer
Intravesical Gemcitabine for Non-muscle Invasive Bladder Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457483/all/Intravesical_gemcitabine_for_non_muscle_invasive_bladder_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical gemcitabine for non-muscle invasive bladder cancer
ID - 457483
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457483/all/Intravesical_gemcitabine_for_non_muscle_invasive_bladder_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
